GLP-1 medications continue to surge in popularity, offering effective solutions for weight management, Type 2 diabetes, and other emerging indications. While these drugs show significant clinical benefits, their skyrocketing costs present a major challenge for self-insured employers. Current solutions fall short at addressing the core issue: ensuring members have access to these medications when appropriate while supporting long-term health and sustainable cost management.
During this webinar, we’ll explore a balanced, more intentional approach to GLP-1 management — one that goes beyond cost-shifting to focus on evidence-based prescribing, member engagement and sustainable outcomes. We’ll discuss:
- How Quantum Health’s new model ensures the right members start GLP-1 therapy through clinically guided readiness assessments and targeted support
- What self-insured employers can do to balance cost control with member outcomes in this rapidly evolving market
- How a human-centered, behavior-first strategy leads to long-term cost savings
- How to successfully graduate members from GLP-1s and onto sustainable, lower-cost strategies
Panelists
Quantum Health
Quantum Health
Vida Health
More like this
Beyond Fertility: Supporting Women's Health at Every Stage
Women’s and family health needs are evolving, and employers must rethink benefits strategies to provide inclusive, comprehensive support. Join industry experts for a conversation on creating equitable benefits that go beyond fertility treatment to improve access, outcomes and cost efficiency.
Learn more
Enhancing Member Confidence and Retention in Medicare Advantage: The Power of Proactive Navigation
Watch our partnered webinar with RISE, as we share thought leadership on the latest strategies for enhancing member experience, improving satisfaction, and closing care gaps.
Learn more
Balancing the Clinical Benefits and Cost of GLP-1s
Join us for an in-depth look at GLP-1 medications, including how they work, why they’re so popular, and the risks associated with taking them. Together we’ll explore strategies to help employers manage the use of these drugs within their benefits plan while also examining medical trends associated with GLP-1s. You’ll leave with insights to help set your organization up for long-term success, both clinically and financially.
Learn more